Gemmer Asset Management LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 13 filers reported holding Astellas Pharma Inc in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gemmer Asset Management LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q2 2021$3,0000.0%1920.0%0.00%
Q1 2021$3,0000.0%1920.0%0.00%
Q4 2020$3,0000.0%1920.0%0.00%
-100.0%
Q3 2020$3,0000.0%1920.0%0.00%0.0%
Q2 2020$3,0000.0%1920.0%0.00%0.0%
Q1 2020$3,000
+50.0%
192
+93.9%
0.00%
Q4 2019$2,000
+100.0%
990.0%0.00%
Q3 2019$1,0000.0%990.0%0.00%
Q2 2019$1,0000.0%99
+57.1%
0.00%
Q1 2019$1,000
-80.0%
63
-79.4%
0.00%
-100.0%
Q3 2018$5,0000.0%3060.0%0.00%0.0%
Q2 2018$5,0000.0%3060.0%0.00%0.0%
Q1 2018$5,0003060.00%
Other shareholders
Astellas Pharma Inc shareholders Q1 2018
NameSharesValueWeighting ↓
THOMAS WHITE INTERNATIONAL LTD 659,892$10,254,0001.47%
TODD ASSET MANAGEMENT LLC 963,505$15,048,0000.46%
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY 694,200$10,843,0000.14%
SCOUT INVESTMENTS, INC. 179,686$2,792,0000.08%
Boston Common Asset Management, LLC 60,610$942,0000.05%
L & S Advisors Inc 10,000$156,0000.04%
QUADRANT CAPITAL GROUP LLC 3,443$49,0000.03%
PARAMETRIC PORTFOLIO ASSOCIATES LLC 1,012,486$15,815,0000.02%
OLD NATIONAL BANCORP /IN/ 12,094$188,0000.01%
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC 181,668$2,838,0000.01%
View complete list of Astellas Pharma Inc shareholders